Google DeepMind launches AlphaGenome 2, advancing genomic AI from tissue-level prediction to single-cell type resolution
Automated summary · Based on collected summaries; not individually verified
Prepared by HotAI
What happened
Google DeepMind releases the genomic research AI model AlphaGenome 2, which predicts how DNA mutations affect specific human cell types. This conditional model uses a specific biological state as an additional input and is trained on over 107 million single-cell atlases from 68 different tissues; it identifies approximately 30% of causal variants on the TenK10K benchmark, compared to only 16% for its fine-tuned predecessor.
Background
What is fine-tuning? Adapt an existing model with training examples
Fine-tuning continues training an existing model, updating all parameters or selected adaptation parameters for a task. It can teach formats or classification conventions, unlike simply uploading a document to a chat. It does not guarantee recall of every fact. Improve instructions and context first, then compare results on held-out questions to assess useful gains.
Reading notes
The event summary comes from collected excerpts. Background passages quote existing HotAI articles to explain terms and do not establish new facts about this event. Check the original sources for product results, conditions and subsequent updates.
Original source
Sources and collection timeline
| Source | Report title | Original publication time | Collected by HotAI |
|---|---|---|---|
| The Decoder | Google DeepMind launches AlphaGenome 2, advancing genomic AI from tissue-level prediction to single-cell type resolution | 2026-11-12 20:09 | 2026-11-12 20:47 |